Aduro Biotech, Inc.;Providence Health & Services-Oregon D/b/a Providence Portland Medical Center
发明人:
LAUER, Peter,BAHJAT, Keith
申请号：
LT11841347
公开号：
LT2640842T
申请日:
2011.11.17
申请国别(地区):
LT
年份:
2018
代理人:
摘要：
The present invention relates to methods of inducing a T-cell response against a EGFRvIII in a subject. These method comprise administering to a subject a composition which expresses at least one immunogenic polypeptide, the amino acid sequence of which comprise a plurality of EGFRvIII polypeptide sequences, the sequence of which each comprise EEKKGNYV (SEQ ID NO: 3), and/or administering the polypeptide itself.
